Zhang Zhuxian, Zhou Chun, Liu Mengyi, Zhang Yuanyuan, Li Huan, He Panpan, Nie Jing, Liang Min, Liu Chengzhang, Song Yun, Liu Lishun, Wang Binyan, Zhang Yan, Li Jianping, Huo Yong, Wang Xiaobin, Xu Xiping, Qin Xianhui
National Clinical Research Center for Kidney Disease, State Key Laboratory for Organ Failure Research, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Shenzhen Evergreen Medical Institute, Shenzhen, 518057, China.
Hypertens Res. 2021 Jul;44(7):830-839. doi: 10.1038/s41440-021-00625-1. Epub 2021 Feb 9.
We aimed to investigate the association between neutrophil counts and first stroke and examine possible effect modifiers among treated hypertensive adults. This is a post hoc analysis of the China Stroke Primary Prevention Trial (CSPPT). A total of 11,878 hypertensive adults with data on neutrophil counts at baseline were included in the current study. The primary outcome was first stroke. During a median follow-up of 4.5 years, 414 (3.5%) participants experienced a first stroke, including 358 with ischemic stroke, 55 with hemorrhagic stroke and one with uncertain type of stroke. Compared with participants in quartile 1 (<2.9 × 10/L) of neutrophil counts, those in the upper quartiles (quartile 2-4 [≥2.9 × 10/L]) had a significantly higher risk of first stroke (HR, 1.35; 95% CI: 1.02, 1.78) or first ischemic stroke (HR, 1.38; 95% CI: 1.02, 1.86). Moreover, a strong positive association between neutrophil counts and first ischemic stroke was found in participants with total homocysteine (tHcy) levels <15 μmol/L (HR, 1.74; 95% CI: 1.17, 2.58; vs. ≥15 μmol/L; HR, 0.91; 95% CI: 0.57, 1.46, P interaction = 0.042) at baseline or time-averaged mean arterial pressure (MAP) ≥102 mmHg (median) (HR, 1.92; 95% CI: 1.27, 2.89; vs. <102 mmHg; HR, 0.89; 95% CI: 0.57, 1.41, P interaction = 0.015) during the treatment period. However, no such association between neutrophil counts and first hemorrhagic stroke was found. In summary, high baseline neutrophil counts were associated with an increased risk of first ischemic stroke among hypertensive patients, especially in those with low tHcy at baseline or high time-averaged MAP during the treatment period.
我们旨在研究中性粒细胞计数与首次卒中之间的关联,并在接受治疗的高血压成年患者中检验可能的效应修饰因素。这是一项对中国卒中一级预防试验(CSPPT)的事后分析。本研究共纳入了11878例有基线中性粒细胞计数数据的高血压成年患者。主要结局为首次卒中。在中位随访4.5年期间,414例(3.5%)参与者发生了首次卒中,其中358例为缺血性卒中,55例为出血性卒中,1例卒中类型不明。与中性粒细胞计数处于四分位数1(<2.9×10⁹/L)的参与者相比,处于较高四分位数(四分位数2 - 4 [≥2.9×10⁹/L])的参与者发生首次卒中(风险比[HR],1.35;95%置信区间[CI]:1.02,1.78)或首次缺血性卒中(HR,1.38;95% CI:1.02,1.86)的风险显著更高。此外,在基线总同型半胱氨酸(tHcy)水平<15 μmol/L(HR,1.74;95% CI:1.17,2.58;与≥15 μmol/L相比;HR,0.91;95% CI:0.57,1.46,交互作用P值 = 0.042)的参与者中,或在治疗期间时间平均平均动脉压(MAP)≥102 mmHg(中位数)(HR,1.92;95% CI:1.27,2.89;与<102 mmHg相比;HR,0.89;95% CI:0.57,1.41,交互作用P值 = 0.015)的参与者中,发现中性粒细胞计数与首次缺血性卒中之间存在强正相关。然而,未发现中性粒细胞计数与首次出血性卒中之间存在此类关联。总之,高血压患者基线中性粒细胞计数高与首次缺血性卒中风险增加相关,尤其是在基线tHcy低或治疗期间时间平均MAP高的患者中。